Antitumorigenic Effect of Tramadol and Synergistic Effect With Doxorubicin in Human Breast Cancer Cells
Open Access
- 26 January 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 811716
- https://doi.org/10.3389/fonc.2022.811716
Abstract
Background: Breast cancer in women is one of the leading causes of cancer mortality worldwide, and curative therapy is the main focus of clinical treatment. Anesthetic-analgesic techniques might alter stress responses and immunity and thereby influence outcomes in cancer patients. This study investigated the effect of tramadol on breast cancer progression and metastasis. Methods: The effects of tramadol on two different subtypes of human breast adenocarcinoma cell lines, MDA-MB-231 and MCF-7, were studied with regard to cell growth, migration, colony formation and invasion and normoxic or hypoxic microenvironment for the expression of hypoxia-inducible factor-1α, reactive oxygen species, epithelial-mesenchymal transition related and cyclin-related proteins. The co-administration of tramadol and doxorubicin was studied to determine whether the effective doxorubicin dose might be reduced in combination with tramadol. Results: The results showed that tramadol inhibited cell growth at concentrations more than 0.5 and more than 1.0 mg/mL in MDA-MB-231 and MCF-7 cells, respectively. Additionally, cell migration, colony formation and invasion were inhibited in a dose-dependent manner by tramadol in both cell lines. The combination of tramadol and doxorubicin induced synergistic effects in MDA-MD-231 cells and, with specific dosage combinations in MCF-7 cells. Conclusions: Tramadol may regulate epithelial-mesenchymal transition and possess cytotoxic effects in breast cancer cells. Tramadol inhibits the progression of breast cancer cells and might be a candidate for combination therapy, especially for triple-negative breast cancer, and is a promising treatment strategy for breast cancer.Funding Information
- Ministry of Science and Technology, Taiwan
This publication has 44 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Involvement of α2‐ and β2‐adrenoceptors on breast cancer cell proliferation and tumour growth regulationBritish Journal of Pharmacology, 2011
- Tramadol toxicity-induced rhabdomyolysisJournal of Emergencies, Trauma, and Shock, 2010
- Clinical Equivalence of Controlled-Release Oxycodone 20 mg and Controlled-Release Tramadol 200 mg after Surgery for Breast CancerPharmacology, 2009
- Tissue-Specific Consequences of Cyclin D1 Overexpression in Prostate Cancer ProgressionCancer Research, 2007
- Effects of tramadol on myocardial ischemia-reperfusion injuryScandinavian Cardiovascular Journal, 2007
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- Prognostic Relevance of Gene Amplifications and Coamplifications in Breast CancerCancer Research, 2004
- Inhibitory effects of tramadol on nicotinic acetylcholine receptors in adrenal chromaffin cells and inXenopusoocytes expressing α7 receptorsBritish Journal of Pharmacology, 2002
- Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HClThe American Journal of Medicine, 1996